ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

47 hedge funds and large institutions have $215M invested in Intra-Cellular Therapies Inc. in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$1.3M
2 +$883K
3 +$778K
4
Morgan Stanley
Morgan Stanley
New York
+$527K
5
State Street
State Street
Massachusetts
+$279K

Top Sellers

1 -$1.07M
2 -$581K
3 -$224K
4
TRCT
Tower Research Capital (TRC)
New York
-$179K
5
Goldman Sachs
Goldman Sachs
New York
-$149K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$441K
27
$425K
28
$307K
29
$300K
30
$255K
31
$228K
32
$218K
33
$218K
34
$215K
35
$215K
36
$190K
37
$87K
38
$60K
39
$57K
40
$25K
41
$23K
42
$18K
43
$14K
44
$10K
45
$4K
46
$193
47
$44
48
49
50